Chronic Pain Clinical Trial
— CIR-predictOfficial title:
Development of a Clinical Prediction Model to Facilitate Decision Making in Interdisciplinary Biopsychosocial Rehabilitation in Patients With Osteoarthritis (OA)
Verified date | November 2022 |
Source | Maastricht University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The goal of this prospective study is to identify variables that can predict whether an interdisciplinary biopsychosocial intervention for patients with osteoarthritis will be successful. Using an observational design, patients admitted to this program during the 3-year period (2019-2021) will be included and data gathered during routine clinical practice at baseline and end of treatment of patients who gave informed consent, will be used. With these data a prediction model will be build and internal validation with bootstrapping will be done.
Status | Active, not recruiting |
Enrollment | 2309 |
Est. completion date | December 31, 2023 |
Est. primary completion date | January 17, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 16 Years and older |
Eligibility | Inclusion Criteria: - Chronic musculoskeletal pain > 3 months and osteoarthritis - Large personal and social dysfunction - Interplay of biological, social and psychological factors maintaining pain and/or disability Exclusion criteria: - Inability to actively participate in treatment (insufficient motivation, limited Dutch language skills, environmental factors, other pending treatments) - Disagreement between patient and care providers on content of treatment - Pending legal procedures that hinder full cooperation |
Country | Name | City | State |
---|---|---|---|
Netherlands | Centrum voor Integrale Revalidatie | Zwolle | Overijssel |
Lead Sponsor | Collaborator |
---|---|
Maastricht University | Centrum voor Integrale Revalidatie (CIR), Pfizer |
Netherlands,
Breugelmans L, Scheffer E, Beckers LWME, Oosterwijk RFA, Nijland G, Smeets RJEM. Systematic description of an interdisciplinary multimodal pain treatment programme for patients with chronic musculoskeletal pain, using the TIDieR checklist. BMC Res Notes. 2022 Oct 11;15(1):320. doi: 10.1186/s13104-022-06211-z. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Brief Illness Perception Questionnaire | Measures the cognitive and emotional representation of illness in a patient | Baseline | |
Other | Pain Self Efficacy Questionnaire | Measures how confident the patient is that he/she will be able to perform daily tasks despite being in pain | baseline | |
Other | Psychological Inflexibility in Pain Scale | Measures psychological inflexibility (avoidance of pain and cognitive fusion with pain) | Baseline | |
Other | Symptom Checklist 90 | Measures to which degree the patient suffers from 90 different physical and psychological symptoms. | Baseline | |
Other | Hospital Anxiety and Depression Scale | Measures feelings of fear and depression, without looking at physical complaints | Baseline | |
Other | General CIR questionnaire | Records general socio-demographic characteristics as well as symptom-related information, co-morbidity and medication levels. | baseline | |
Other | Pain Catastrophising Scale | Measures degree of catastrophizing | Baseline | |
Other | Checklist Individual Strength | Measures subjective tiredness | Baseline | |
Other | Twelve-Item Short Form Health Survey | Measures physical and mental functioning | Baseline | |
Other | Patient Specific Complaint | Measures a patient's functional status by inquiring for three self-selected daily activities to which degree the patient is limited in this activity by his/her pain complaints | Baseline | |
Primary | Pain Disability Index | Measures to which degree pain prevents the patient from participating in daily activities. Improvement equal or higher than Minimal Clinically Important Change (MCID; which is 9 points) is defined as successful treatment, and all others as not successful treatment Population will be dichotomized into successful or non-successful treatment and this will be the dependent variable for the logistic regression analysis used to build the prediction model | baseline (start of treatment) and 10 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|